Regencell Bioscience Holdings Limited

NasdaqCM:RGC Stock Report

Market Cap: US$77.9m

Regencell Bioscience Holdings Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Yat-Gai Au

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure10.8yrs
CEO ownership81.2%
Management average tenure3yrs
Board average tenure3.3yrs

Recent management updates

Recent updates

Here's Why We're Not Too Worried About Regencell Bioscience Holdings' (NASDAQ:RGC) Cash Burn Situation

Nov 18
Here's Why We're Not Too Worried About Regencell Bioscience Holdings' (NASDAQ:RGC) Cash Burn Situation

Slow And Steady Wins The Race With Regencell Bioscience

Aug 16

CEO

Yat-Gai Au (51 yo)

10.8yrs

Tenure

Mr. Yat-Gai Au serves as the Chief Financial Officer of Armitage Technologies Holding Ltd. Mr. Au served as Compliance Officer and Executive Director of Armitage Technologies Holding Ltd. He joined Armitag...


Leadership Team

NamePositionTenureCompensationOwnership
Yat-Gai Au
Founderno datano data81.22%
$ 63.3m
Michelle Chan
Financial Controller & Principal Financial Officer3yrsno datano data
Wai Hong Chung
COO, Chief Strategy Officer & Director3.3yrsUS$245.64kno data
Antonia Assang
Senior Vice President of Project Managementno datano datano data
Yat-Pui Au
Chief Business Officer1.8yrsno datano data

3.0yrs

Average Tenure

50yo

Average Age

Experienced Management: RGC's management team is considered experienced (3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Yat-Gai Au
Founder10.8yrsno data81.22%
$ 63.3m
Wai Hong Chung
COO, Chief Strategy Officer & Directorless than a yearUS$245.64kno data
Yee Wah Hui
Independent Director3.3yrsno datano data
Paul J. Niewiadomski
Independent Director3.3yrsno datano data
Wing-Yan Lo
Independent Director2.9yrsno datano data

3.3yrs

Average Tenure

52yo

Average Age

Experienced Board: RGC's board of directors are considered experienced (3.3 years average tenure).